Forty-eight-Week Safety and Efficacy On-Treatment Analysis of Ibalizumab in Patients with Multi-Drug Resistant HIV-1

por Emu, Brinda, Fessel, W Jeffery, Schrader, Shannon, Kumar, Princy N, Richmond, Gary, Win, Sandra, Weinheimer, Steven, Marsolais, Christian, Lewis, Stanley
Publicado 2017